Moreover, in humans with insulin resistance and obesity, the levels of OPA1 in the skeletal muscle are reduced compared to healthy patients (Houzelle et al., 2021). This evidence concerns the gene OPA1 and obesity due to melanocortin 4 receptor deficiency.